Clinical trial
Dermatopharmacokinetic Trial of LEO 80185 Gel
NCT02605057 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dermatopharmacokinetic Trial of LEO 80185 Gel
- Lead sponsor
- LEO Pharma
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 30, 2015
- Completion date
- July 31, 2016
- Enrollment
- 32 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
psoriasis vulgaris